Norihiko Shiraishi

CSO at NANO MRNA

Speaker

Nori leads NANO MRNA on research and development of mRNA therapeutics, focusing on to establish rich pipeline through internal research and external collaborations with academia, venture companies and pharmaceutical companies.

Prior to NANO MRNA, Nori served as senior management of corporate planning in Kyowa Kirin Co., Ltd.

He served as global clinical project lead for multiple drugs, low molecular weight compounds, antibodies, and biologics, in oncology, hematology and nephrology area.

His research background spans from microbilogy, bioinformatics, and molecular biology.